Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Tristan Pascart MD, PhD

Tristan Pascart MD, PhD

Full Professor, Department of Rheumatology, Lille Catholic University Hospital, Lille, France

Tristan Pascart is a rheumatologist in the North of France. His clinical and research special interests are gout and CPPD, with a focus on using dual-energy computed tomography (DECT) to assess crystal burden and how it relates to disease activity and severity. As principal investigator for imaging studies involving DECT, Dr. Pascart started the CRYSTALILLE inception cohort in 2016 now including 500 patients with crystal diseases. He is part of the steering committee for the development of the ACR/EULAR classification criteria for CPPD with a focus on the imaging aspects.

His research also focuses on therapeutic aspects of gout and CPPD. He was the first author of the 2020 French recommendations for the management of gout, and was the principal investigator of the COLCHICORT trial, first ever RCT performed in acute CPP crystal arthritis.

He was appointed co-Editor in Chief of the Gout, Urate, and Crystal Deposition Disease journal, flagship journal of the international society for crystal deposition diseases Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN).


Dr. Pascart has no relevant disclosures.